Feedback PLC – Dr Balaji Ganeshan talking at UK Radiological Congress 2015
Dr. Balaji Ganeshan, Chief Scientist & New Business Officer at Feedback PLC, (and group companies TexRAD and CCI Ltd) will be giving a talk entitled “Quantifying Tumour heterogeneity with TexRAD texture analysis on CT and MRI” Where: at the Guerbet Laboratories Ltd stand at UK Radiological Congress 2015 in Liverpool, UK (30th June 4pm and […]
Feedback company TexRAD wins the inaugural Sussex Impact Award at the University of Sussex
Sussex research has improved lives and changed the outside world in areas from lad culture to chemical weapons and sustainable food, as recognised by an inaugural awards ceremony on campus on16 June. The winners of the first Sussex Impact and Research Awards were announced at a celebratory reception in the Jubilee building. Sussex researchers from across […]
Feedback PLC announces the first server sale of TexRAD in Canada
Feedback plc (FDBK), the medical imaging software company, is pleased to announce its first server sale for research purposes in Canada of the Group’s TexRAD texture analysis software. The software will be installed in the Department of Diagnostic Radiology at the McGill University Health Centre’s Montreal General Hospital site. The MUHC is one of the […]
Feedback PLC – Statement re Share Price Movement
The Board of Feedback plc (FDBK), the medical imaging software company, notes the increase in the Company’s share price, trading volume and speculation on bulletin boards. As announced on the 3 June 2015, the Company completed a successful placing with Director participation which has attracted positive media comment however the Board can confirm they know […]
Feedback (FDBK) raises £200,000 to fund TexRAD development
Feedback plc (FDBK), the medical imaging software company, is pleased to announce that it has placed 11,111,111 new ordinary shares of 0.25 pence each at a price of 1.8 pence per ordinary share with a number of existing and new investors raising £200,000. The Placing has been completed by Peterhouse Corporate Finance Limited. The proceeds […]
Feedback PLC – Collaboration with the University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Feedback plc (FDBK), the medical imaging software company, is pleased to announce that it has signed a research agreement with The University of Texas MD Anderson Cancer Center in Houston, Texas, USA, to investigate the potential future clinical application of Feedback’s TexRAD texture analysis software on computed tomography (CT) image data of patients with kidney […]
Feedback PLC announces preliminary results from the Oxford Stone Group using TexRAD research software in the analysis of kidney stones
Feedback plc previously announced on 13 April 2015 that it had signed a research agreement with the Oxford Stone Group at the University of Oxford & Oxford University Hospital NHS Trust, UK to investigate the potential future clinical application of Feedback’s TexRAD texture analysis software on computed tomography (CT) image data of patients with kidney […]
Dr Balaji Ganeshan, Chief Scientist and New Business Officer at Feedback PLC is interviewed by Zak Mir on TipTV
chicagobearsjerseyspop
Feedback announces a new drug trial and provides a trading update
Feedback plc notes that TexRAD, its texture analysis software product will be used by Imaging Endpoints II, LLC, its exclusive partner, for imaging core lab purposes in a forthcoming drug trial in the United States. A study will shortly be commenced of colorectal cancer patients (Stage IIIc) with either Regorafenib or Standard of Care (No […]
Feedback announces a collaboration with Princess Alexandra Hospital, Brisbane, AU
Feedback plc is pleased to announce that it is undertaking a study cheap mlb jerseys using wholesale nfl jerseys its TexRAD research product with the Diagnostic Radiology department at the Princess Alexandra Hospital in Brisbane, Australia to assess the potential for clinical workflow integration for TexRAD quantitative computed tomography specifically focused on Минска non-small cell […]